CERo Therapeutics Holdings, Inc. (CERO) — Dilution Risk Analysis

Current Snapshot

CERo Therapeutics Holdings, Inc. (CERO) has a DilutionWatch score of 51/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
71,630,992 Source
Public Float
43,137,836 Source
Float as % of Outstanding
60.2%

Dilution Risk Score

Score: 51/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

4 shelf registration or ATM offering filings detected in recent history.

Recent filing forms in the source payload: XBRL 1, 424B3 4, 8-K 3, 3 1, 4 1.

FormFiledAccession
xbrl 2026-06-30 xbrl-7543-xbrl_warrant
424B3 2026-05-01 0001213900-26-050932
8-K 2026-05-01 0001213900-26-050951
424B3 2026-05-01 0001213900-26-050953
3 2026-04-21 0001213900-26-046328
4 2026-04-21 0001213900-26-046329
424B3 2026-04-15 0001213900-26-044124
8-K 2026-04-14 0001213900-26-043519
424B3 2026-04-14 0001213900-26-043520
8-K 2026-03-11 0001213900-26-025817

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $729,596,950 Source
Cash runway 999 months Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 51/10) Source
Cash Runway
999 months Source
ATM Offering Capacity Remaining
$729,596,950 Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.